Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
about
The diagnosis of and treatment recommendations for anxiety disordersPharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringConstructing Causal Diagrams for Common Perinatal Outcomes: Benefits, Limitations and Motivating Examples with Maternal Antidepressant Use in PregnancyNeonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Prenatal antidepressant exposure: clinical and preclinical findings.Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI ExposureContinuing medical education: SSRIs and pregnancy.Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesEffects of neonatal fluvoxamine administration on the physical development and activity of the serotoninergic system in white rats.Preventing mental health problems in offspring by targeting dietary intake of pregnant women.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics.Major depressive disorder: new clinical, neurobiological, and treatment perspectives.Bright light therapy in pregnant women with major depressive disorder: study protocol for a randomized, double-blind, controlled clinical trial.Effect of prenatal administration of venlafaxine on postnatal development of rat offspringPerformance of a Culturally Tailored Cognitive-Behavioral Intervention Integrated in a Public Health Setting to Reduce Risk of Antepartum Depression: A Randomized Controlled Trial.Pharmacokinetics of drugs in pregnancy.Cardiac dysfunction and prenatal exposure to venlafaxine.Nutritional interventions in depression and perinatal depression.A review of SSRIs and SNRIs in neuropathic pain.Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.Adverse reactions to duloxetine in depression.Dental management of the female patient.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.The German guidelines for the treatment of anxiety disorders.Depression During Pregnancy and Postpartum.Antidepressants and pregnancy.Prescription drug use among pregnant women in opioid Maintenance Treatment.Safety of SSRIs during pregnancy: a controlled study.Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine.Antidepressants and pregnancy.The effect of lifestyle-based education to women and their husbands on the anxiety and depression during pregnancy: a randomized controlled trial.Effects of neonatal fluoxetine exposure on behavior across development in rats selectively bred for an infantile affective trait.Cardiac Outcomes After Perinatal Sertraline Exposure in Mice.Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.Sertraline alters multidrug resistance phosphoglycoprotein activity in the mouse placenta and fetal blood-brain barrier.Neonatal fluoxetine exposure alters motor performances of adolescent rats.[Peripartum depression and grief after pregnancy loss: special problem areas in obstetrics].
P2860
Q27001768-69291617-AB4C-450E-AC54-EDBD88BE3325Q27027293-1C461C82-211C-4219-9CB9-F4D652E9089EQ28385738-7AD36C2A-3DCF-4208-8E67-F009FD5466EAQ30249670-BA616982-1DD1-4129-BA64-603E681A8790Q30415540-70D747AA-B385-420E-83E6-52AA58263394Q30469931-2AD666B9-AE4C-495A-B412-4145FEAF8E5CQ33671166-7A2B864D-AC87-4F4D-8F46-0D6DE6E039A2Q33834340-2291F640-837E-406F-A929-55A4788546D0Q34237681-66C931BE-A795-49EF-ABC4-7268BAC2006DQ34394292-FE4FD6F7-93F8-4F5E-AF85-07E21E0C5AFDQ34507022-3CF1B9E4-1069-43E7-BF18-5F9E712EA169Q34623350-B7B817E8-E1C4-4FF7-ADA1-80E35514D8D7Q35090255-95D2A99F-A053-42D9-8C6D-B5A19D450DE8Q35786090-1EBD763B-F779-4E9B-8F92-7DDEF206E2E4Q36096664-56986F1F-007B-4767-9200-A85631296818Q36184774-DC563374-3F4B-42E8-97ED-585AB82A6646Q36361644-FF7E2524-6B15-4F17-A181-F0FBF22BC625Q36641940-6784C332-0B84-4ABB-93E7-5BEC336180F4Q36734138-A73305B6-1BC3-405B-A5AF-DE57B11E1091Q36797574-735AAB90-EA5C-4697-AA9E-DBF6B698E449Q36895974-DB50AF7E-A8D7-434D-BF99-C4977F746F46Q37773988-A8CC9D7E-6B36-4AD3-99EB-EFB65DD3272DQ37777007-119AC8D9-D5A5-437B-B0EA-AF972C0CE428Q37872294-FBA27EEC-042C-40C5-8506-C1604FE21394Q38067479-E19B4A42-F25F-40E2-B89D-15DF3ED384B7Q38123516-05437771-96E7-4BC4-B17A-1B3A1A98F864Q38268948-BFCFF33A-94C0-4B43-A33D-1E2508646E27Q38734781-9A2C9998-83D4-4A41-AE62-9EA1F3BC1CF2Q42697244-A3E32FF7-3A6E-4821-A5D8-ED36B5E3C2ABQ44335502-A4E49F51-4D88-4CFB-8E18-0A666672A57EQ44670288-45D5D583-C908-4A9F-9FD1-4123DA1DD7FFQ45949600-EB5BACA9-BD3A-4F49-9F1E-EB991D6CD069Q46091139-925EE0C3-98C1-45F2-A7D8-18BDEC872CCAQ47429968-3E6767CF-ACD2-41E3-82C4-AE4764642CF7Q47772971-793180AE-77E9-4880-A3D7-18F354C09C76Q47777271-9E64D1B1-3A3F-40B1-9BE0-DED7F2E8CE7CQ48062592-9AED9920-809F-47B1-BCED-5A99A57A5A3BQ48563473-C49EBD7E-E9D5-4873-AF89-9F74ED2197CCQ49114726-870E343E-A189-43F4-8A5E-5264B195F24FQ50778191-B49BBB92-6843-4DEB-B91B-E217206991C5
P2860
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety concerns associated wit ...... ts during pregnancy: a review.
@en
Safety concerns associated wit ...... ts during pregnancy: a review.
@nl
type
label
Safety concerns associated wit ...... ts during pregnancy: a review.
@en
Safety concerns associated wit ...... ts during pregnancy: a review.
@nl
prefLabel
Safety concerns associated wit ...... ts during pregnancy: a review.
@en
Safety concerns associated wit ...... ts during pregnancy: a review.
@nl
P2093
P1476
Safety concerns associated wit ...... ts during pregnancy: a review.
@en
P2093
Arianna Testi
Corrado Blandizzi
Luca Antonioli
Marco Tuccori
Mario Del Tacca
Matteo Fornai
Narcisa Ghisu
Rocchina Colucci
Sabrina Montagnani
Tiberio Corona
P304
P356
10.1016/J.CLINTHERA.2009.07.009
P478
P577
2009-06-01T00:00:00Z